Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 146

1.

The relationship between chronic glycaemic control and oxidative stress in type 2 diabetes mellitus.

Whiting PH, Kalansooriya A, Holbrook I, Haddad F, Jennings PE.

Br J Biomed Sci. 2008;65(2):71-4.

PMID:
19055108
2.

Urinary enzyme measurements as early indicators of renal insult in type 2 diabetes.

Kalansooriya A, Jennings P, Haddad F, Holbrook I, Whiting PH.

Br J Biomed Sci. 2007;64(4):153-6.

PMID:
18236735
3.

Serum cystatin C, enzymuria, tubular proteinuria and early renal insult in type 2 diabetes.

Kalansooriya A, Holbrook I, Jennings P, Whiting PH.

Br J Biomed Sci. 2007;64(3):121-3.

PMID:
17910281
4.

How I play financial catch-up.

Whiting PH.

Med Econ. 2006 Apr 21;83(8):47-8. No abstract available.

PMID:
16749383
5.

Interaction of eicosanoids and nitric oxide in renal reperfusion injury.

Weight SC, Waller JR, Bradley V, Whiting PH, Nicholson ML.

Transplantation. 2001 Aug 27;72(4):614-9.

PMID:
11544419
6.

Rapamycin reduces expression of fibrosis-associated genes in an experimental model of renal ischaemia reperfusion injury.

Jain S, Bicknell GR, Whiting PH, Nicholson ML.

Transplant Proc. 2001 Feb-Mar;33(1-2):556-8. No abstract available.

PMID:
11266957
7.

Interactions between homocyst(e)ine and nitric oxide during acute submaximal exercise in adult males.

De Crée C, Whiting PH, Cole H.

Int J Sports Med. 2000 May;21(4):256-62.

PMID:
10853696
8.
9.

Human renal medullary interstitial cells and analgesic nephropathy.

Whiting PH, Tisocki K, Hawksworth GM.

Ren Fail. 1999 May-Jul;21(3-4):387-92.

PMID:
10416217
10.

Urinary biomarkers: roles in risk assessment to environmental and occupational nephrotoxins: monitoring of effects and evaluation of mechanisms of toxicity.

Price RG, Wedeen R, Lichtveld MY, Lybarger JA, Porter GA, Fels L, Stolte H, Safirstein RL, Mueller PW, Manley S, Whiting PH, Gomez RA, Finn WF.

Ren Fail. 1999 May-Jul;21(3-4):xiii-xviii. No abstract available.

PMID:
10416200
11.

Chemically induced analgesic nephropathy in the rat monitored by proton-electron double-resonance imaging (PEDRI).

Seimenis I, Foster MA, Lurie DJ, Hutchison JM, Whiting PH, Payne S.

Magn Reson Med. 1998 Aug;40(2):280-6.

PMID:
9702710
12.

Streptozotocin-induced diabetes is associated with increased renal lipoxygenase activity.

Stewart VC, Whiting PH, Bell JA, Hawksworth GM.

Biochem Soc Trans. 1998 May;26(2):S134. No abstract available.

PMID:
9649809
13.

Human renal lipoxygenase.

Stewart VC, Whiting PH, Bell JA, Hawksworth GM.

Biochem Soc Trans. 1997 Nov;25(4):S623. No abstract available.

PMID:
9450051
14.

The effect of desferrioxamine on the development of renal dysfunction in streptozotocin-induced diabetes.

Whiting PH, Jiffri E, Thomson L, Beaton W, Williamson FW, Long WF.

Biochem Soc Trans. 1997 Nov;25(4):S570. No abstract available.

PMID:
9449998
15.

Ischaemia-reperfusion injury during peripheral arterial surgery--the effect of nitric oxide.

Whiting PH, Naylor R, Cooper GG, Engeset J, Macauley EM.

Biochem Soc Trans. 1997 Aug;25(3):389S. No abstract available.

PMID:
9388619
16.

Ketoconazole and fluconazole inhibition of the metabolism of cyclosporin A by human liver in vitro.

Omar G, Whiting PH, Hawksworth GM, Humphrey MJ, Burke MD.

Ther Drug Monit. 1997 Aug;19(4):436-45.

PMID:
9263386
17.

The excretion mechanism of the spin label proxyl carboxylic acid (PCA) from the rat monitored by X-band ESR and PEDRI.

Seimenis I, Foster MA, Lurie DJ, Hutchison JM, Whiting PH, Payne S.

Magn Reson Med. 1997 Apr;37(4):552-8.

PMID:
9094077
18.
19.

Muscle protein release following down hill walking.

Forrester W, Maughan RJ, Broom J, Whiting PH.

Biochem Soc Trans. 1996 May;24(2):318S. No abstract available.

PMID:
8736976
20.

Kidney and urine enzyme activity in experimental gentamicin nephrotoxicity in the Sprague-Dawley rat.

Brown D, Brown J, Whiting PH.

Biochem Soc Trans. 1996 May;24(2):317S. No abstract available.

PMID:
8736975
21.

Altered renal intermediary metabolism and the onset of renal dysfunction in the streptozotocin diabetic rat.

Jiffri E, Broom J, Whiting PH.

Biochem Soc Trans. 1996 May;24(2):264S. No abstract available.

PMID:
8736922
22.

Acute phase proteins and recombinant IL-2 therapy: prediction of response and survival in patients with colorectal cancer.

Simpson WG, Heys SD, Whiting PH, Eremin O, Broom J.

Clin Exp Immunol. 1995 Feb;99(2):143-7.

23.

Transfer of immunoglobulin G across the isolated perfused human placental lobule.

Duncan JI, Armstrong-Fisher SS, Urbaniak SJ, Abramovich DR, Whiting PH, Page KR.

Reprod Fertil Dev. 1995;7(6):1547-50.

PMID:
8743162
24.

Interleukin-2 therapy and renal enzyme excretion in patients with metastatic colorectal cancer.

Heys SD, Eremin O, Whiting PH.

Nephron. 1995;69(4):483-4. No abstract available.

25.

Renal impairment associated with the pre-operative administration of recombinant interleukin-2.

Deehan DJ, Heys SD, Broom J, Eremin O, Whiting PH.

Clin Sci (Lond). 1994 Nov;87(5):513-8.

PMID:
7874838
26.

HDL cholesterol concentrations in healthy volunteers.

Whiting PH, Robertson J, Maughan RJ.

Biochem Soc Trans. 1994 Nov;22(4):437S. No abstract available.

PMID:
7698455
27.

Pre-operative recombinant interleukin-2 and increased nephrotoxicity.

Deehan DJ, Heys SD, Broom J, Eremin O, Whiting PH.

Biochem Soc Trans. 1994 Nov;22(4):425S. No abstract available.

PMID:
7698444
28.

Changes in spermidine/spermine N-acetyltransferase activity in vivo in response to the immunosuppressive agent, mycophenolic acid.

Ross FM, Whiting PH, Wallace HM.

Biochem Soc Trans. 1994 Nov;22(4):400S. No abstract available.

PMID:
7698422
30.

A comparison of the antitumor effects of cyclosporin A in HepG2 and MOLT 4 cells.

Strachan G, Whiting PH, Wallace HM.

Biochem Soc Trans. 1994 May;22(2):129S. No abstract available.

PMID:
7958200
31.

Acute and chronic nephrotoxicity associated with immunosuppressive drugs.

Whiting PH.

Curr Opin Nephrol Hypertens. 1994 Mar;3(2):174-81. Review.

PMID:
7531104
32.

Alleviation of experimental cyclosporin A nephrotoxicity by low dose aspirin in the rat.

Adams KE, Brown PA, Heys SD, Whiting PH.

Biochem Pharmacol. 1993 Dec 3;46(11):2104-8.

PMID:
8267661
33.

The effects of retinoids and terbinafine on the human hepatic microsomal metabolism of cyclosporin.

Shah IA, Whiting PH, Omar G, Ormerod AD, Burke MD.

Br J Dermatol. 1993 Oct;129(4):395-8.

PMID:
8217751
34.

Chronic cyclosporin A (CsA) nephrotoxicity in the rat: the effect of calcium blockade with verapamil.

Shaikh MG, Heys SD, Brown PA, Whiting PH.

Int J Exp Pathol. 1993 Aug;74(4):389-96.

35.

Comparative effects of rapamycin, FK 506 and cyclosporine on antibody production, lymphocyte populations and immunoglobulin isotype switching in the rat.

Thomson AW, Propper DJ, Woo J, Whiting PH, Milton JI, Macleod AM.

Immunopharmacol Immunotoxicol. 1993 Aug;15(4):355-69.

PMID:
7693791
36.

Physiological variations in the urinary excretion of pyridinium crosslinks of collagen.

McLaren AM, Isdale AH, Whiting PH, Bird HA, Robins SP.

Br J Rheumatol. 1993 Apr;32(4):307-12.

PMID:
8461924
37.

The reversal of experimental cyclosporin A nephrotoxicity by thromboxane synthetase inhibition.

Grieve EM, Hawksworth GM, Simpson JG, Whiting PH.

Biochem Pharmacol. 1993 Mar 24;45(6):1351-4.

PMID:
8466554
38.

Lithium clearance measurements during recombinant interleukin 2 treatment: tubular dysfunction in man.

Heys SD, Eremin O, Franks CR, Broom J, Whiting PH.

Ren Fail. 1993;15(2):195-201.

PMID:
8469787
39.

Interleukin 2 therapy in cancer: identification of responders.

Broom J, Heys SD, Whiting PH, Park KG, Strachan A, Rothnie I, Franks CR, Eremin O.

Br J Cancer. 1992 Dec;66(6):1185-7.

40.

Glomerulotubular function in patients undergoing moderate surgical stress.

Anderson DA, Rothnie IJ, Broom J, Keenan RA, Whiting PH.

Ren Fail. 1992;14(2):169-73.

PMID:
1636023
41.

Differential effects of FK 506 and cyclosporine on hair regrowth in the DEBR model of alopecia areata.

Sainsbury TS, Duncan JI, Whiting PH, Hewick DS, Johnson BE, Thomson AW, Oliver RF.

Transplant Proc. 1991 Dec;23(6):3332-4. No abstract available.

PMID:
1721453
42.

Effects of FK 506 on human hepatic microsomal cytochrome P-450-dependent drug metabolism in vitro.

Ali Shah I, Whiting PH, Omar G, Thomson AW, Burke MD.

Transplant Proc. 1991 Dec;23(6):2783-5. No abstract available.

PMID:
1721276
43.

The effect of rapamycin on renal function in the rat: a comparative study with cyclosporine.

Whiting PH, Adam BJ, Woo J, Hasan NU, Thomson AW.

Toxicol Lett. 1991 Oct;58(2):169-79.

PMID:
1683033
44.

Toxicity of rapamycin--a comparative and combination study with cyclosporine at immunotherapeutic dosage in the rat.

Whiting PH, Woo J, Adam BJ, Hasan NU, Davidson RJ, Thomson AW.

Transplantation. 1991 Aug;52(2):203-8.

PMID:
1871790
45.

Soluble IL-2 receptor and CD25 cells in psoriasis: effects of cyclosporin A and PUVA therapy.

Duncan JI, Horrocks C, Ormerod AD, Powles AV, Whiting PH, Fry L, Thomson AW.

Clin Exp Immunol. 1991 Aug;85(2):293-6.

46.

The effect of calcium blockade with verapamil on experimental cyclosporine nephrotoxicity.

Orugun EO, Smart LM, Whiting PH.

Transplant Proc. 1991 Feb;23(1 Pt 1):354-5. No abstract available.

PMID:
1990550
47.

The effect of the thromboxane receptor antagonist GR32191B on cyclosporine-induced nephrotoxicity.

Mobb GE, Whiting PH, Feehally J, Veitch PS, Bell PR.

Transplant Proc. 1991 Feb;23(1 Pt 2):1241-3. No abstract available.

PMID:
1824892
48.

FK 506 inhibition of cyclosporine metabolism by human liver microsomes.

Omar G, Shah IA, Thomson AW, Whiting PH, Burke MD.

Transplant Proc. 1991 Feb;23(1 Pt 2):934-5. No abstract available.

PMID:
1703356
49.

Effect of thromboxane synthetase inhibition and angiotensin converting enzyme inhibition on acute cyclosporin A nephrotoxicity.

Grieve EM, Hawksworth GM, Simpson JG, Whiting PH.

Biochem Pharmacol. 1990 Nov 15;40(10):2323-9.

PMID:
2244933
50.

The pharmacokinetics of gamma-glutamyl-L-dopa in normal and anephric rats and rats with glycerol-induced acute renal failure.

Boateng YA, Barber HE, MacDonald TM, Petrie JC, Lee MR, Whiting PH.

Br J Pharmacol. 1990 Oct;101(2):301-6.

Supplemental Content

Loading ...
Support Center